Search "headache prevention routine" and you'll find a dozen versions of the same evening checklist — drink water, take magnesium, go to bed on time, put the phone down. It's a reasonable-sounding list, which is exactly why it's worth checking against actual trial data instead of taking it on faith. Some pieces of it hold up well. Others are backed by a single small study, or by evidence collected in people with a diagnosed migraine disorder rather than headaches in general. Below is what the research on each piece actually says, including where it's thinner than the wellness-blog version suggests.
A randomized controlled trial published in Family Practice (Spigt et al., 2012) assigned 102 people with recurrent headaches and below-average fluid intake to either increase their daily water intake by about 1.5 liters or continue as usual. The water group reported a statistically meaningful improvement on a validated migraine-specific quality-of-life scale, and 47% rated their improvement as "much better" versus 25% in the control group. An earlier pilot version of the same research group's work found a reduction in total headache hours over two weeks. That said, a broader systematic review of randomized trials testing daily water intake changes noted that most individual studies in this space are small, and effects on headache frequency specifically haven't consistently reached statistical significance. The honest summary: hydration is a low-risk, plausible piece of a routine, backed by real if limited trial data — not a proven fix on its own.
A 2012 joint guideline from the American Academy of Neurology and the American Headache Society rated oral magnesium "probably effective" for migraine prevention (Level B) — the highest evidence grade given to any nutraceutical reviewed in that guideline, based on multiple placebo-controlled trials. Studied doses generally fall in the 400–600 mg per day range of elemental magnesium, most commonly as magnesium oxide or magnesium citrate, typically evaluated over two to three months before judging whether it's helping. The leading proposed mechanism involves magnesium's role in blocking excess neuronal excitability tied to migraine's cortical spreading depression. The most common side effect across trials is diarrhea, which is dose-related and usually resolves by lowering the dose.
An honest gap worth naming: most of the trial evidence behind that Level B rating used magnesium oxide or citrate, not magnesium glycinate. Glycinate is a real, well-absorbed form that tends to be gentler on the gut, which is why it's a common practical choice — but it hasn't been the specific form in most of the published migraine-prevention trials. Anyone with kidney disease should talk to a doctor before starting a daily magnesium regimen, since impaired kidneys can't clear excess magnesium efficiently.
A randomized controlled trial by Schoenen and colleagues (Neurology, 1998) first showed that 400 mg of riboflavin daily reduced migraine attack frequency compared with placebo over three months. Later systematic reviews of the accumulated trial data — including a 2017 review in the Journal of Clinical Pharmacy and Therapeutics — describe the evidence as generally favorable and consistently well tolerated, while also noting that trial quality varies and sample sizes are modest, which is why reviewers stop short of calling it definitively established. One notable practical point: 400 mg is roughly 200 times the amount in a typical multivitamin, so reaching the studied dose means taking a dedicated riboflavin supplement, not just a general multivitamin. The one consistently reported side effect is bright yellow urine — harmless, and actually a sign the dose is being absorbed and excreted.
A multicenter, placebo-controlled trial (Gaul et al., 2015) tested riboflavin, magnesium, and coenzyme Q10 together against placebo. Worth stating plainly: the trial missed its own pre-registered primary endpoint — the reduction in migraine days (6.2 to 4.4 with the supplement vs. 6.2 to 5.2 with placebo) did not reach statistical significance, and the authors attributed this partly to the study being underpowered at roughly 55 people per group. Several secondary measures did favor the supplement combination, including pain intensity and headache-impact scores. It's a fair example of real research not lining up neatly behind a tidy marketing claim — read as a mixed result, not a clean win.
Sleep researchers consistently find that any disruption to a person's normal sleep pattern — going to bed much later than usual, sleeping in, jet lag, shift changes — is one of the most commonly self-reported migraine triggers, sometimes even more so than short sleep duration by itself. One study following people prospectively found that a night of perceived poor sleep quality was linked to roughly a 22% higher chance of a headache the next morning. A 2019 systematic review and meta-analysis of sleep-focused behavioral interventions for migraine and tension-type headache found that improving sleep habits was associated with reduced headache frequency, though the individual trials varied in quality and design. The relationship also runs in both directions — headache disorders themselves disrupt sleep — which is part of why a consistent sleep-wake schedule is considered a foundational, low-cost piece of headache management rather than a minor detail.
The mechanism here is fairly well established even where headache-specific trial data is thinner: evening exposure to screen light suppresses melatonin release and delays the body's normal wind-down signal, and poor sleep is itself a documented headache trigger, so screen habits can act indirectly through sleep disruption. Separately, screen glare, sustained close-range focus, and reduced blinking contribute to eye strain, which some people with migraine identify as a direct trigger independent of sleep. Commonly suggested, low-risk adjustments include dimming screens or switching to a warmer color temperature in the evening, taking a short break every 45–60 minutes during heavy screen use, and giving yourself a screen-free window before bed. These are reasonable, low-cost habits consistent with the broader sleep-hygiene evidence above, even though few trials have isolated "screen time" alone as a headache variable.
Two picks track directly to the research above. First, a magnesium glycinate supplement — chosen for better gut tolerability than the oxide form used in most trials, at a dose in the studied 400–600 mg elemental magnesium range, and worth discussing with a doctor first if you have kidney disease or take other medications. Second, a single-ingredient riboflavin (vitamin B2) supplement dosed at 400 mg, matching the dose used in the trials above rather than the trace amount in a standard multivitamin. As with any recommendation here, we link to authorized retailers and may earn a commission at no extra cost to you. As an Amazon Associate, we earn from qualifying purchases.
Search Magnesium Glycinate on Amazon →This is general research information, not medical advice, and it isn't a substitute for a diagnosis from a doctor. Anyone with frequent or severe headaches should get evaluated before starting a new supplement, especially if pregnant, nursing, managing kidney disease, or taking other medications that could interact with magnesium. Seek immediate medical care for a sudden, severe headache unlike any before it, a headache following a head injury, or a headache with fever, stiff neck, confusion, vision changes, weakness, or slurred speech. Results from any wellness routine vary and aren't guaranteed.
Most of the strongest trial evidence here — magnesium, riboflavin, and their combination — was collected in people with a diagnosed migraine disorder, not headaches in general, so how well it generalizes to occasional tension-type headache is less clear. The hydration trial evidence is real but comes from a small number of modestly sized studies, and a broader review found the effect on headache frequency specifically wasn't consistent across trials. The riboflavin-magnesium-CoQ10 combination trial actually missed its own primary endpoint, even though secondary measures looked favorable. And the screen-and-light section rests more on plausible, well-supported mechanisms (melatonin suppression, sleep disruption, eye strain) than on trials that isolated screen habits as a standalone headache variable. None of this is a routine that reliably erases headache days for everyone — it's a set of individually reasonable, mostly low-risk habits, each with a different strength of evidence behind it.
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare provider before starting any new supplement, especially with a diagnosed medical condition or other medication.